Advertisement
Home Blog Page 3754
For older adults presenting to their primary care providers with a new visit for back pain

Earlier Physical Therapy May Help Older Patients With Back Pain

0
Extent of improvement in symptoms may be greater among those referred for early PT
Confetti-like depigmentation may be a marker of rapidly progressing vitiligo

Confetti-Like Depigmentation May Predict Vitiligo Progression

0
Review finds confetti-like pattern may predict rapid disease progression
Patients age 70 or older are at greater risk of unanticipated hospital admission within 30 days of ambulatory surgery

Improved Care Transitions Needed Post Ambulatory Surgery

0
Age independently associated with hospital admission
Local degranulation of mast cells is associated with acute ocular inflammation

Mast Cell Degranulation Linked to Ocular Pathology

0
Provokes acute ocular inflammation, dilation, permeability of choroidal vessels
Self- and caregiver-reported history of eczema is valid for identifying atopic dermatitis

Self-Reported Eczema Valid for Detecting Atopic Dermatitis

0
High specificity and positive predictive value for self-, caregiver-reported ever history of eczema
About one-third of survivors of sepsis or septic shock are readmitted within 30 days

One-Third of Septic Shock Survivors Readmitted

0
Readmitted patients have higher chronic illness burden, prevalence of health care-linked sepsis
Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat locally advanced basal cell carcinoma that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation.

FDA Approves Odomzo for Recurring Basal Cell Carcinoma

0
Medication is designed to inhibit the Hedgehog pathway
Technivie (ombitasvir

FDA Approves Technivie for Hepatitis C

0
For people with chronic hepatitis C genotype 4
A new diagnostic to differentiate between HIV-1 antibodies

FDA Approves Test to Differentiate HIV Viruses

0
Among people two years and older
Children with attention-deficit/hyperactivity disorder undergoing sedation for magnetic resonance imaging do not have a higher dose requirement for propofol

No Need for More Propofol for MRI Sedation in ADHD

0
Children with ADHD undergoing MRI do not need higher doses of sedation